INSM
Insmed Inc
117.80$
-3.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Insmed Inc (INSM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -935 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.2 | -21 | -32 | -24 | -11 | -25 | -28 | -42 | -25 | -12 | -11 | -7.7 | -30 | -31 | -47 | -64 | -101 | -147 | -160 | -258 | -251 | -219 | -363 | -400 | -536 | -684 | -935 | |
| 0.1 | 0.8 | 1.5 | 0.3 | 0.1 | 0.0 | 13 | 3.4 | 0.4 | 1.0 | 0.7 | 0.1 | 0.3 | 0.6 | 0.7 | 1.1 | 2.0 | 2.4 | 2.9 | 4.8 | 10 | 14 | 14 | 10 | 11 | 11 | 16 | |
| – | – | 0.1 | 0.1 | – | – | – | 0.9 | 0.5 | 0.9 | 2.5 | 0.4 | 1.6 | 3.0 | 8.7 | 11 | 16 | 18 | 18 | 26 | 27 | 36 | 46 | 58 | 75 | 97 | 153 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 28 | 2.1 | 8.7 | 11 | 16 | 18 | 18 | 28 | 27 | 36 | 71 | 46 | – | – | – | |
| 0.2 | 2.1 | 4.0 | -3.5 | -0.7 | 2.2 | 0.2 | 4.6 | -6.3 | 1.1 | -5.1 | -1.7 | 1.5 | 7.4 | -0.4 | 1.8 | -0.6 | 8.6 | 11 | 16 | -63 | -3.0 | -59 | 6.6 | -39 | -3.2 | -80 | |
| 0.1 | 1.3 | 0.3 | 0.3 | 0.0 | 0.0 | 0.0 | 5.0 | 0.0 | 0.0 | 0.0 | 6.7 | 1.0 | 0.3 | 0.8 | 5.4 | 3.5 | 4.2 | 3.0 | 15 | 42 | 6.8 | 7.3 | 9.9 | 13 | 22 | 33 | |
| -4.4 | -4.6 | 11 | 11 | – | – | – | -5.0 | 8.6 | 13 | 19 | 6.0 | 34 | 62 | 1.3 | -5.3 | -3.5 | -4.2 | -3.0 | -15 | -42 | -6.8 | -64 | -35 | -224 | -583 | -65 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 26 | 69 | 110 | 228 | 1.1 | 381 | 8.8 | 281 | 272 | 292 | 312 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -0.1 | 20 | -0.2 | 4.7 | -0.3 | 30 | 395 | 378 | -0.9 | -0.9 | 322 | 332 | -1.2 | 147 | -4.9 | |
| 0.3 | 97 | 0.2 | 0.2 | 13 | 4.6 | 37 | 53 | 18 | -2.1 | 2.9 | -0.2 | -0.1 | 45 | 68 | 115 | 228 | 31 | 381 | 387 | 285 | 271 | 613 | 793 | 168 | 1,341 | 954 | |
| -11 | 71 | -20 | -24 | 2.2 | -20 | 9.6 | 5.3 | 1.4 | -1.4 | 11 | -2.0 | 4.1 | 76 | 23 | 45 | 124 | -120 | 219 | 114 | -7.6 | 45 | 184 | 357 | -592 | 73 | -45 | |
| -7.3 | -23 | -32 | -24 | -11 | -25 | -28 | -47 | -25 | -12 | -11 | -1.0 | -31 | -31 | -47 | -70 | -104 | -151 | -163 | -273 | -293 | -226 | -371 | -410 | -550 | -706 | -968 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.